- Home
- LNSR vs RAPT Comparison
LNSR vs RAPT Comparison
Compare LNSR & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNSR
- RAPT
- Stock Information
- Founded
- LNSR 2004
- RAPT 2015
- Country
- LNSR United States
- RAPT United States
- Employees
- LNSR N/A
- RAPT N/A
- Industry
- LNSR Medical Electronics
- RAPT Biotechnology: Pharmaceutical Preparations
- Sector
- LNSR Health Care
- RAPT Health Care
- Exchange
- LNSR Nasdaq
- RAPT Nasdaq
- Market Cap
- LNSR 63.4M
- RAPT 59.1M
- IPO Year
- LNSR N/A
- RAPT 2019
- Fundamental
- Price
- LNSR $9.29
- RAPT $1.25
- Analyst Decision
- LNSR
- RAPT Hold
- Analyst Count
- LNSR 0
- RAPT 10
- Target Price
- LNSR N/A
- RAPT $6.00
- AVG Volume (30 Days)
- LNSR 107.2K
- RAPT 627.1K
- Earning Date
- LNSR 02-27-2025
- RAPT 03-06-2025
- Dividend Yield
- LNSR N/A
- RAPT N/A
- EPS Growth
- LNSR N/A
- RAPT N/A
- EPS
- LNSR N/A
- RAPT N/A
- Revenue
- LNSR $48,868,000.00
- RAPT N/A
- Revenue This Year
- LNSR $25.07
- RAPT N/A
- Revenue Next Year
- LNSR $24.95
- RAPT N/A
- P/E Ratio
- LNSR N/A
- RAPT N/A
- Revenue Growth
- LNSR 21.29
- RAPT N/A
- 52 Week Low
- LNSR $2.67
- RAPT $0.79
- 52 Week High
- LNSR $12.13
- RAPT $10.05
- Technical
- Relative Strength Index (RSI)
- LNSR 42.92
- RAPT 53.72
- Support Level
- LNSR $9.66
- RAPT $1.10
- Resistance Level
- LNSR $11.80
- RAPT $1.30
- Average True Range (ATR)
- LNSR 0.95
- RAPT 0.09
- MACD
- LNSR -0.25
- RAPT 0.02
- Stochastic Oscillator
- LNSR 4.38
- RAPT 72.00
About LNSR LENSAR Inc.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency and reproducibility by providing imaging, simplified procedure planning, efficient design and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The consumable portion of the system consists of a disposable patient interface device, or PID, kit and a procedure license. Each procedure on each system requires the use of a PID kit.
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.